Related Experiment Video
Updated: Aug 25, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Pediatric drug utilization evaluation of cefepime and piperacillin/tazobactam
Priengrutai Prasopchoknapaporn1, Sophida Boonsathorn1, Chonnamet Techasaensiri1
1Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Insights
Drug utilization evaluation (DUE) improved antibiotic appropriateness in pediatric patients. This systematic review highlights DUE
Area of Science:
- Pediatric Pharmacology
- Antimicrobial Stewardship
- Health Services Research
Background:
- Drug utilization evaluation (DUE) systematically assesses medication use to optimize antibiotic prescribing.
- This study focused on cefepime and piperacillin/tazobactam in a pediatric tertiary care setting.
Purpose of the Study:
- To evaluate the effectiveness of DUE in improving the appropriateness of cefepime and piperacillin/tazobactam prescriptions for pediatric patients.
- To identify factors associated with inappropriate antibiotic use.
Main Methods:
- A quasi-experimental study conducted at Ramathibodi Hospital from March 2020 to August 2021.
- Inclusion criteria: hospitalized children (1 month to 20 years) receiving cefepime or piperacillin/tazobactam.
- Retrospective evaluation of prescriptions pre-DUE implementation and voluntary DUE use during the study period.
Main Results:
- The DUE group showed significantly higher appropriateness of empirical antibiotic prescriptions (93.5% vs. 83.5%, P=0.003).
- DUE was significantly associated with appropriate empirical prescribing (adjusted OR 5.32).
- Inappropriate prescribing was linked to critical care wards and urinary tract infections (UTIs).
Conclusions:
- Drug utilization evaluation can enhance the appropriate empirical use of cefepime and piperacillin/tazobactam in pediatric populations.
- Critical care settings and UTIs were associated with suboptimal empirical antibiotic treatment.
Background:
Drug utilization evaluation (DUE) is a systematic, criteria-based assessment of medicine that aims to optimize the appropriateness of antibiotic prescription. This study aimed to evaluate the performance of the DUE on prescriptions of two commonly used antibiotics in a pediatric population, cefepime and piperacillin/tazobactam, in a tertiary care hospital.
Methods:
This quasi-experimental study was conducted at the Department of Pediatrics, Ramathibodi Hospital, between March 2020 and August 2021. All hospitalized children aged 1 month to 20 years who received at least one dose of cefepime or piperacillin/tazobactam were enrolled. Before implementing the DUE, cefepime and piperacillin/tazobactam prescriptions were retrospectively evaluated using the DUE criteria. During the 6 month DUE implementation period, physicians voluntarily chose to use DUE to assess the prescriptions' appropriateness. Demographic data, antibiotic use, and clinical data were recorded.
Results:
There were 304 prescriptions of cefepime and piperacillin/tazobactam, with 108 empirical prescriptions (72 patients) in the DUE group and 158 prescriptions (138 patients) in the non-DUE group. The appropriateness of empirical prescriptions of cefepime and piperacillin/tazobactam was significantly higher in the DUE group (93.5% vs. 83.5%; P = 0.003). Drug utilization evaluation was significantly associated with appropriate empirical prescriptions (adjusted OR 5.32: 95% CI 1.80-15.73; P = 0.003). Prescriptions in critical care wards and urinary tract infections (UTIs) were associated with not fulfilling the DUE criteria for appropriateness.
Conclusions:
Drug utilization evaluation could improve the appropriateness of empirical use of cefepime and piperacillin/tazobactam in pediatric patients. Patients in critical care units and with UTIs appeared to be associated with inappropriate empirical treatment.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Antimicrobial Effectiveness
Drug Elimination by Renal Route: Tubular Secretion
Urine Studies II: Urine Culture and Sensitivity Test
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Factors Affecting Drug Response: Overview